Literature DB >> 12607665

Preoperative shock determines outcome for acute type A aortic dissection.

Stewart M Long1, Curtis G Tribble, Daniel P Raymond, Steven M Fiser, Aditya K Kaza, John A Kern, Irving L Kron.   

Abstract

BACKGROUND: Acute type A aortic dissection is a life-threatening catastrophe. Surgical results have not improved.
METHODS: The charts of all 70 patients surgically treated for acute type A primary aortic dissection during the period of January 1988 through April 2001 were reviewed.
RESULTS: Average age was 59 +/- 2 years. Comorbidities included hypertension (66%), coronary artery disease (17%), and Marfan's syndrome (11%). At presentation, 23% were in shock, 17% had neurologic dysfunction, and 36% had coronary ischemia. The aortic valve was preserved in 55. Distal aortic anastomosis was performed under aortic cross-clamp ("closed") in 32 and "open" under circulatory arrest in 38 patients. Operative mortality was 18.6% (13 of 70 patients). Patients in shock had an operative mortality of 50% compared with stable patients of 9% (p = 0.0002). Mortality was similar regardless of technique. Univariate analysis revealed preoperative shock (p = 0.0002), tamponade (p = 0.003), and neurologic deficit (p = 0.02) to be associated with mortality. Multivariate analysis revealed hemodynamic stability (odds ratio = 0.10, p = 0.04) and outside transfer (odds ratio = 0.12, p = 0.03) to be negative predictors of mortality. Of 57 survivors, follow-up was 93% complete for an average of 46 +/- 6 months. The overall late reoperation rate was 24.6% (14 of 57 patients) at 50.3 +/- 12.3 months. Twelve patients (21%) underwent future aortic aneurysmal repair. No difference in reoperation rate was seen comparing "closed" (26%) with "open" (18%; p = 0.46). Of 42 preserved native valves, only 3 (7.1%) needed future valve replacement.
CONCLUSIONS: In our experience, operative mortality was determined by preoperative hemodynamic instability. Technique did not impact survival or late reoperation. Early diagnosis and repair is critical to improving survival.

Entities:  

Mesh:

Year:  2003        PMID: 12607665     DOI: 10.1016/s0003-4975(02)04536-8

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  7 in total

1.  [German Registry for Acute Aortic Dissection Type A (GERAADA): initial results].

Authors:  L O Conzelmann; T Krüger; I Hoffmann; B Rylski; J Easo; M Oezkur; K Kallenbach; O Dapunt; M Karck; E Weigang
Journal:  Herz       Date:  2011-09       Impact factor: 1.443

2.  Stable haemodynamics associated with no significant electrocardiogram abnormalities is a good prognostic factor of survival for acute type A aortic dissection repair.

Authors:  Tsu-Ming Chien; Wei-Yu Li; Hao Wen; Jiann-Woei Huang; Chong-Chao Hsieh; Huai-Min Chen; Chaw-Chi Chiu; Ying-Fu Chen
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-11-19

3.  A safe and rapid direct true lumen cannulation for acute type A aortic dissection.

Authors:  Taro Kanamori; Tetsuya Ichihara; Hidehito Sakaguchi; Takehiko Inoue
Journal:  Gen Thorac Cardiovasc Surg       Date:  2013-02-21

Review 4.  Acute aortic syndromes and thoracic aortic aneurysm.

Authors:  Vijay S Ramanath; Jae K Oh; Thoralf M Sundt; Kim A Eagle
Journal:  Mayo Clin Proc       Date:  2009-05       Impact factor: 7.616

Review 5.  The cannulation strategy in surgery for acute type A dissection.

Authors:  Tomonobu Abe; Akihiko Usui
Journal:  Gen Thorac Cardiovasc Surg       Date:  2016-09-20

6.  Early Mortality in Patients who Received Extensive Surgical Management for Acute Type A Aortic Dissection - Analysis of 452 Consecutive Cases from a Single-center Experience.

Authors:  Ahmed Sayed Abdelhameed; Feng Xin; Xiang Wei
Journal:  Braz J Cardiovasc Surg       Date:  2020-08-01

7.  Surgical rescues for critical hemopericardium complicated by acute type A aortic dissection: Emergent subxiphoid pericardiotomy or cardiopulmonary bypass first?

Authors:  Chun-Yu Lin; Meng-Yu Wu; Chi-Nan Tseng; Yu-Sheng Chang; Yuan-Chang Liu; Cheng-Hui Lu; Feng-Chun Tsai
Journal:  PLoS One       Date:  2020-03-02       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.